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INTRODUCTION
Breast metastases from extramammary malignancies are 
uncommon, as most metastatic breast tumors are from the 
contralateral breast [1,2]. Extrapulmonary metastases from 
primary osteosarcomas are also uncommon, with metastatic 
osteosarcoma to the breast being extremely rare. Although 
several cases of metastatic osteosarcoma to the breast have 
been reported in the literature [3-6], none of them have ex-
hibited the imaging features of this rare form of metastasis. 
Herein, we report a case of metastatic osteosarcoma to the 
breast, focusing on imaging features seen using dedicated 
breast imaging modalities. 
CASE REPORT
A 58-year-old Korean woman was referred to our institution 
for a mass in the right distal tibia detected with magnetic reso-
nance imaging performed at an outside clinic (Figure 1A). The 
patient had been suffering from pain in her right ankle for a 
week. An open biopsy was performed, and the tumor was 
pathologically diagnosed as an osteoblastic conventional os-
teosarcoma (Figure 1B). She was transferred to our institution, 
where she subsequently underwent chest radiography and 
computed tomography (CT) for routine baseline evaluation. 
Although there was no evidence of pulmonary metastasis, two 
calcified nodules were discovered, one in the right breast and 
the other in the anterior mediastinum (Figure 2A). Based on 
imaging features, benign granuloma and metastasis were con-
sidered in the differential diagnosis, and short-term follow-up 
was recommended because the patient was scheduled for neo-
adjuvant intra-arterial chemotherapy. Chest CT performed 
three weeks later revealed size increases of the calcified masses 
(Figure 2B), raising the suspicion for metastasis. Therefore, the 
patient was referred to the breast radiologist for biopsy. 
Diagnostic mammography (Figure 3A) showed a dense cal-
cified mass in the right upper breast, with spiculated margins. 
Breast ultrasonography (US) of the right upper breast (Figure 
3B) revealed a 1.5 cm dense calcified mass with posterior 
shadowing. Owing to the dense calcifications seen in the mass, 
percutaneous US-guided core needle biopsy was considered 
difficult to perform, and excisional biopsy was recommended 
to make a pathologic diagnosis. After the third cycle of neoad-
juvant chemotherapy, excisional biopsies of the breast and me-
diastinal masses were performed. Specimen mammography 
(Figure 4A) of the excised breast mass showed the dense calci-
fied mass within the specimen, confirming complete excision 
of the mass. Pathologic examination revealed a high-grade 
spindle cell tumor with osteoid matrix production (Figure 4B, C). 
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Figure 1. Magnetic resonance imaging and pathologic features of the osteosarcoma involving the right tibia. (A) A 4.8-cm-sized osteosclerotic mass 
(arrows) with periosteal reaction is seen in the diaphysis of the right distal tibia. (B) This mass was diagnosed as conventional osteosarcoma, osteo-
blastic type, showing lacy architectural pattern on excisional biopsy (H&E stain, ×200).
Figure 2. Metastatic osteosarcoma detected on chest computed tomography (CT). (A) Two calcified masses were seen on initial chest CT, one in the 
right breast, and one at the anterior mediastinum (arrows). (B) Follow-up chest CT performed 3 weeks later revealed size increase of these masses, 
breast mass from 11 to 14 mm and mediastinal mass from 12 to 15 mm (arrows), raising the suspicion for metastasis. 
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Figure 4. Specimen mammography and the pathology features of the right breast mass. (A) Specimen mammography reveals the dense calcified 
mass (arrows) seen on mammography in the right breast, confirming complete excision of the mass. (B) Similar features are seen on gross specimen, 
which reveals a dense calcified mass within the breast tissue. (C) Microscopic examination shows a mass with predominant osteoid matrix production 
(arrows) (H&E stain, ×40). (D) Immunohistochemically, these tumor cells were positive for cluster of differentiation 99 (CD99), negative for estrogen re-
ceptor (ER), progesterone receptor (PR), and cytokeratin 5/6 (CK5/6). These findings are consistent with those of metastatic osteosarcoma to the 
breast, rather than primary metaplastic carcinoma of the breast (×100).
Figure 3. Mammography and breast ultrasonography (US) examinations of the right breast mass. (A) Mediolateral oblique views of mammography 
show a dense calcified mass (arrow) with spiculated margins in the right upper breast. (B) Breast US performed on the same day shows a 1.5-cm 
dense calcified mass with posterior shadowing. Percutaneous biopsy was considered difficult due to the dense calcifications, and the patient under-
went excisional biopsy.
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Immunohistochemical staining revealed positivity for cluster 
of differentiation 99 (CD99) and negativity for estrogen recep-
tor (ER), progesterone receptor (PR), and basal cytokeratins 
(CK5/6), which further suggested metastatic osteosarcoma to 
the breast (Figure 4D). The mediastinal mass was also excised 
via video-assisted thoracoscopic surgery, confirming metasta-
tic osteosarcoma. Currently, the patient is being treated with 
adjuvant chemotherapy, with no clinical or radiological find-
ings of recurrence after 2 months of follow-up.
DISCUSSION
Osteosarcoma is the most frequent skeletal malignancy and 
commonly involves the long bones of the extremities. Osteo-
sarcoma most commonly metastasizes to the lung, followed 
by the skeleton, pleura, and heart [7]. In contrast, breast and 
soft tissues are extremely rare sites for metastatic osteosarco-
ma. The prognoses of metastatic patients remain poor even 
though the outcomes of patients with localized osteosarcoma 
have markedly improved due to the introduction of multi-
organ chemotherapy. Extrapulmonary metastasis at initial di-
agnosis was an independent predictive factor of poor overall 
survival in a recent study [8]. 
Incidences of breast metastases from extra-mammary ma-
lignancies are reportedly very low. Most cases are incidentally 
found on CT during staging rather than on dedicated breast 
imaging (Table 1) [9]. The breast metastasis in our case was 
also initially detected by chest CT, as in another case recently 
reported by Chan et al. [5], in which the metastatic osteosar-
coma appeared as multiple discrete, round nodules with dense 
calcification. In a case reported by Roebuck et al. [6], meta-
static osteosarcoma to the breast was also seen by chest CT as 
a noncalcified, soft-tissue nodule in the right subareolar re-
gion. Another report included metastatic osteosarcoma to the 
breast detected on bone scan images, in which they exhibited 
intense tracer uptake at the chest wall outside the skeletal con-
finements. This was later proven to be a metastatic osteosar-
coma [3]. Although a couple of case reports have presented 
mammographic features of primary breast osteosarcoma 
[10,11], to the best of our knowledge, no studies have reported 
the mammographic findings of metastatic osteosarcoma to 
the breast. 
In our case, the spiculated margins of the metastatic mass 
were well delineated on mammography, which strongly sug-
gests malignant processes, including metastasis, rather than 
benign dense calcifications. On the other hand, US features of 
the lesion appeared relatively benign, as it was a well-circum-
scribed mass with dense calcifications. Mammography is 
more sensitive and accurate in evaluating breast calcifications, 
and as in our case, mammography may be more useful in dif-
ferentiating between primary malignancies or metastases 
containing calcifications and benign calcified masses, such as 
involuting fibroadenomas. Additionally, as in our case, immu-
nohistochemical staining helps to differentiate metastatic os-
teosarcoma from other malignant breast lesions, such as 
metaplastic carcinoma with osteosarcomatous differentiation. 
Table 1. Cases published in literature on metastatic osteosarcoma to the breast
Year Author
Age 
(yr)*
Primary 
site
Metastatic site Imaging modality and findings Pathologic type
1999 Roebuck et al. [6] 15 Tibia Breast, lung, femur Breast US
   Lobulated hypoechoic solid mass
Poorly differentiated sarcoma 
  with myxoid differentiation
Chest CT 
   Soft-tissue nodule without calcification in the right breast
2009 Basu et al. [3] 35 Humerus Breast 99mTc-MDP bone scan Not available
    Focal tracer uptake outside the skeletal outline
2010 Vieira et al. [4] 51 Femur Breast, lung Breast imaging – Not available High-grade pleomorphic 
  sarcoma
2013 Chan et al. [5] 16 Tibia Breast, lung, 
  peritoneum
Chest and abdomen CT 
    Multiple discrete, round nodules with dense calcification 
in both breasts
Not available
Current 58 Tibia Breast, Chest CT Conventional osteosarcoma, 
  case    mediastinum    Dense calcified masses in breast and mediastinum   osteoblastic type
Breast US
   Dense calcified mass with posterior shadowing
Mammography
   Dense calcified mass with spiculated margins
US=ultrasonography; CT=computed tomography; MDP=methylene diphosphonate.
*Age on the year of diagnosis of the breast metastasis.
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CD99 is a commonly expressed osteosarcoma antigen [12], 
while ER and PR are well-known breast cancer biomarkers. 
Basal cell type cytokeratins, including CK5/6, are widely used 
for detecting myoepithelial differentiation, which is observed 
in sarcomatoid metaplastic carcinoma [13]. 
As there are no specific management guidelines for this ex-
tremely rare condition, metastatic osteosarcoma to the breast 
has been treated similarly to other metastatic masses. The 
general treatment strategy for osteosarcoma consists of local 
control by complete surgical excision and systemic chemo-
therapy. Complete surgical resection of all suspected meta-
static lesions reportedly has survival benefits, and this is the 
only chance of a cure [14]. Both neoadjuvant and adjuvant 
chemotherapy are generally administrated before and after 
the surgery [14], but as of yet, there is no universal consensus 
on treatment of metastatic osteosarcoma to the breast [15]. 
In conclusion, although its incidence is very low, metastatic 
osteosarcoma should be considered when a dense calcified 
breast mass is found in a patient with a history of osteosarco-
ma. Dedicated breast imaging, such as mammography, is ca-
pable of providing clues to differentiate between metastatic 
osteosarcoma to the breast and benign calcified breast masses. 
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